Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 150 of 399 entries
View as:

High-Dose Chemotherapy, Total-Body Irradiation, and Autologous Stem Cell Transplantation or Bone Marrow Transplantation in Treating Patients With Hematologic Cancer or Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00060255 Org: User:
Start: 12/31/91 End: 02/28/13 Due: 02/28/14

Functional Near-Infrared Spectroscopy and Virtual Reality Relaxation Programs for Pain Management in Patients With Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06456411 Org: User:
Start: 07/12/22 End: 07/12/26 Due: 07/12/27

Nintedanib in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Up to Two Previous Chemotherapy Regimens

Phase: N/A Priority: Normal
NCT ID: NCT01948141 Org: User:
Start: 01/30/14 End: 08/16/16 Due: 08/16/17

Calcitriol, Ketoconazole, and Dexamethasone in Treating Patients With Metastatic or Unresectable Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00238225 Org: User:
Start: 11/30/04 End: - Due: -

Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1

Phase: N/A Priority: Normal
NCT ID: NCT02650986 Org: User:
Start: 07/14/17 End: 07/14/32 Due: 07/14/33

Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy

Phase: N/A Priority: Normal
NCT ID: NCT00054522 Org: User:
Start: 04/30/02 End: 03/31/06 Due: 03/31/07

Irinotecan and Selenium in Treating Patients With Advanced Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00112892 Org: User:
Start: 08/31/04 End: 12/31/07 Due: 12/31/08

Erlotinib and Radiation Therapy in Treating Older Patients With Stage I, Stage II, Stage III, or Stage IV Esophageal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00524121 Org: User:
Start: 03/31/06 End: 10/31/11 Due: 10/31/12

Propranolol With Standard Chemoradiation for Esophageal Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT04682158 Org: User:
Start: 04/01/21 End: 04/01/27 Due: 04/01/28

Paricalcitol and Zoledronate in Treating Patients With Relapsed or Refractory Multiple Myeloma or Other Plasma Cell Disorders

Phase: N/A Priority: Normal
NCT ID: NCT00258258 Org: User:
Start: 08/31/05 End: - Due: -

Pazopanib Hydrochloride and Bevacizumab in Treating Patients With Previously Untreated Metastatic Kidney Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01684397 Org: User:
Start: 11/21/12 End: 12/20/25 Due: 12/20/26

Biomarkers and Clinical Features of Metastatic Breast Cancer in Patients Treated With CDK4/6 Inhibitors

Phase: N/A Priority: Normal
NCT ID: NCT04526587 Org: User:
Start: 07/03/20 End: 07/03/30 Due: 07/03/31

Fentanyl With or Without Bupivacaine in Reducing Pain in Patients Undergoing Video-Assisted Chest Surgery

Phase: N/A Priority: Normal
NCT ID: NCT00538499 Org: User:
Start: 10/28/04 End: 09/30/09 Due: 09/30/10

Photodynamic Therapy Using HPPH in Treating Patients With Stage 0 Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00526461 Org: User:
Start: 02/29/04 End: 04/30/14 Due: 04/30/15

A Cytomegalovirus-Directed Vaccine (CMV-alphaDC1) for Preventing Cytomegalovirus Infection or Reactivation in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Phase: N/A Priority: Normal
NCT ID: NCT05589844 Org: User:
Start: 03/31/23 End: 11/16/25 Due: 11/16/26

Intensive Locoregional Chemoimmunotherapy for Recurrent Ovarian Cancer Plus Intranodal DC Vaccines

Phase: N/A Priority: Normal
NCT ID: NCT02432378 Org: User:
Start: 09/04/15 End: 06/19/25 Due: 06/19/26

BAY 59-8862 in Treating Patients With Non-Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00054314 Org: User:
Start: 03/31/02 End: - Due: -

Photodynamic Therapy Using HPPH in Treating Patients With Obstructive Esophageal Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00060268 Org: User:
Start: 01/31/97 End: 06/30/04 Due: 06/30/05

Single-Fraction SBRT Versus Standard Palliative Radiation Therapy in Treating Patients With Metastatic Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04068649 Org: User:
Start: 11/18/19 End: 11/18/27 Due: 11/18/28

Lenalidomide With or Without Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia

Phase: N/A Priority: Normal
NCT ID: NCT00096044 Org: User:
Start: 03/31/04 End: 06/30/15 Due: 06/30/16

Combination Chemotherapy and Thalidomide in Treating Patients With Stage I, Stage II, or Stage III Multiple Myeloma

Phase: N/A Priority: Normal
NCT ID: NCT00054158 Org: User:
Start: 08/31/04 End: - Due: -

Anhydrovinblastine in Treating Patients With Advanced Recurrent Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT00003882 Org: User:
Start: 03/31/99 End: 09/30/00 Due: 09/30/01

Photodynamic Therapy Using Topical Aminolevulinic Acid in Treating Patients With Actinic Keratosis

Phase: N/A Priority: Normal
NCT ID: NCT00524485 Org: User:
Start: 05/31/05 End: 05/31/09 Due: 05/31/10

Irinotecan and Celecoxib in Treating Patients With Unresectable or Metastatic Colorectal Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00084721 Org: User:
Start: 03/31/05 End: - Due: -

A Food Security Intervention for the Prevention of Cancer in Low-income Families

Phase: N/A Priority: Normal
NCT ID: NCT07039630 Org: User:
Start: 06/30/25 End: 12/30/25 Due: 12/30/26